Cancer

Profound Medical to Release Second Quarter 2024 Financial Results on August 8 – Conference Call to Follow

TORONTO, July 18, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device…

6 months ago

Cosmos Health’s Cana Secures Additional Contract Manufacturing Agreement with Provident Pharmaceuticals for 700,000 Units, Bringing Total Order Book to 5.02 Million Units

CHICAGO, IL / ACCESSWIRE / July 18, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified,…

6 months ago

Baptist Health Breaks Ground On Third Combined ER and Urgent Care Facility

Innovative Facility on Bardstown Road Continues Expansion of Patient-First Healthcare ModelLOUISVILLE, KY / ACCESSWIRE / July 18, 2024 / Baptist…

6 months ago

Manifold and American Cancer Society Collaborate to Modernize Observational Study Management

Leading cancer research institution will use the Manifold Observational Study technology to deliver a better experience for participants, study managers,…

6 months ago

Brittany Davison, CPA, CA, Joins BioVaxys as Business Advisor

VANCOUVER, BC, July 18, 2024 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the "Company") is pleased…

6 months ago

K2 Laboratory Obtains NDC Codes for Two Investigational Drugs

K2 Laboratory recently announced that its two investigational drugs, Brain Rehabilitation oral solution and Telomerase Inhibitor oral solution, have successfully…

6 months ago

Tufts Medical Center Becomes First Hospital in Massachusetts to Adopt MOLLI Surgical’s Breast Cancer Technology

MOLLI® 2 System offers breast cancer patients unmatched surgical precision and enhanced comfort BOSTON, July 18, 2024 /PRNewswire/ -- MOLLI Surgical…

6 months ago

Boehringer Ingelheim and GoodRx announce exclusive patient affordability initiative for Adalimumab-adbm injection, Boehringer’s biosimilar to Humira®

First biosimilar with an exclusive low cash price on the GoodRx platform RIDGEFIELD, Conn. and SANTA MONICA, Calif., July 18,…

6 months ago

Jaguar Health to Report Phase 3 OnTarget Trial Results for Its Cancer Supportive Care Drug Crofelemer on July 23rd and Hold Investor Webcast that Morning

Webcast on Tuesday, July 23rd at 8:30 AM Eastern will include updates on Jaguar's cancer supportive care portfolio, including participation…

6 months ago

Microbot Medical Completes the Enrollment of Clinical Sites in Its Pivotal Human Clinical Trial with the Addition of Memorial Sloan Kettering Cancer Center

As the third and final clinical site, Memorial Sloan Kettering Cancer Center joins Brigham Women’s Hospital and Baptist Hospital of…

6 months ago